Curacin A


Curacin A is a hybrid polyketide synthase /nonribosomal peptide synthase derived natural product produced isolated from the cyanobacterium Lyngbya majuscula. Curacin A belongs to a family of natural products including jamaicamide, mupirocin, and pederin that have an unusual terminal alkene. Additionally, Curacin A contains a notable thiazoline ring and a unique cyclopropyl moiety, which is essential to the compound's biological activity. Curacin A has been characterized as potent antiproliferative cytotoxic compound with notable anticancer activity for several cancer lines including renal, colon, and breast cancer. Curacin A has been shown to interact with colchicine binding sites on tubulin, which inhibits microtubule polymerization, an essential process for cell division and proliferation.

Biosynthesis

The synthetic enzymes for Curacin A are found in a gene cluster with 14 open reading frames with the nomenclature CurA through CurN. Analysis of the pathway demonstrated the presence of one NRPS/PKS hybrid module located on CurF, one HMG-CoA synthase cassette located on CurD, and seven monomodular PKS modules. CurA contains a unique GCN5-related N-acetyltransferase loading domain and an associated acyl carrier protein. The loading module tethers an acetyl group to the ACP that then condenses with one of three tandem ACPs present in the adjacent module of CurA. An hydroxymethylglutaryl-CoA synthase cassette catlyzes the formation of hydroxymethylglutaryl acid by the addition of an malonyl-CoA unit to the terminal ketide of the aceto-acetyl-ACP moiety of ACP1,ACP2, or ACP3. subsequent enzymes, including a unique heme independent halogenase catalyze the formation of a cyclopropyl ring. A cysteine specific NRPS module located on CurF follows after cyclopropyl ring formation, and due to the activity of a cyclizing condensation domain, forms a thiazole ring attached to the cylcopropyl moiety from previous reactions in the pathway. Seven standalone PKS modules follow to extend the growing polyketide chain with S-adenosyl methionine dependent methylations occurring at positions 10 and 13. A rare offloading strategy involving a sulfotransferase is employed by the final curacin synthase module. The sulfotransferase sulfates the hydroxyl group of carbon 15, which activates the molecule for decarboxylation and terminal alkene formation.

Cyclopropyl ring formation

The CurB, CurC, and CurD are responsible for the formation of HMG-ACP3. HaI, from the CurA gene, is a unique non-heme halogenase that goes through a purported Fe=O intermediate to add a chlorine atom onto an unactivated carbon atom. After chlorination, ECH1 acting as a dehydratates HMG-ACP3 to 3-methylgultaconyl-ACP3 and ECH2 performs the required decarboxylation. Finally,an unusual ER catalyzed cyclization reaction, purported to go through a substitution like mechanism, forms the cyclopropane ring. The added chlorine atom assists in the decarboxylation step and likely serves as the leaving group during cyclopropane ring formation.